Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Annals of Hematology|April 3, 2021
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patientsDinesh Bhurani, Jyotsna Kapoor, Neha Yadav, et al.
Indian Journal of Pathology & Microbiology|February 15, 2017
Phenotypic expression of HbO Indonesia in two Indian families and its interaction with sickle hemoglobinAmar Das Gupta, Anita Nadkarni, Pallavi Mehta, et al.
Therapeutic Advances in Infectious Disease|April 29, 2021
Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it outJyotsna Kapoor, Sumeet Prakash Mirgh, Vishvdeep Khushoo, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 14, 2016
Five Rare β Globin Chain Hemoglobin Variants in IndiaRoshan B Colah, Anita Nadkarni, Ajit Gorakshakar, et al.
Leukemia Research|August 22, 2022
Pneumocystis jirovecii pneumonia [PJP]: An unrecognized concern in AML patients on VenetoclaxSujay Rainchwar, Rohan Halder, Reema Singh, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 2, 2022
High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 ProtocolJyotsna Kapoor, Sumeet Prakash Mirgh, Narendra Agrawal, et al.
European Journal of Haematology|July 5, 2022
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high riskPallavi Mehta, Jyotsna Kapoor, Aakanksha Singh, et al.
American Journal of Blood Research|July 29, 2021
Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy - novel avenues for lesser venetoclax duration and patients with baseline infections from a developing countrySumeet Mirgh, Archana Sharma, Mohammad Rizwan Mohammad Anwar Shaikh, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 20, 2019
Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From IndiaNeha Yadav, Mukul Aggarwal, Pallavi Mehta, et al.
Indian Journal of Cancer|October 3, 2023
Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysisNeha Yadav, Sumeet P Mirgh, Mukul Aggarwal, et al.
Pageof 4